<DOC>
	<DOC>NCT00954122</DOC>
	<brief_summary>The purpose of the study is to determine whether treatment with quetiapine XR (Seroquel XR) tablets for 3 weeks will improve their agitation when they have acute psychosis.</brief_summary>
	<brief_title>Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Requirement for treatment of acute episode of schizophrenia (according to DSMIV diagnostic criteria) PANSS total score of Â³ 75 CGI &gt; 4 Any DSMIV (Diagnostic and Statistical Manual of Mental Disorders 4th Edition) Axis I disorder not defined in the inclusion criteria Patients who, in the opinion of the investigator, pose an imminent risk of suicide or a danger to self or others Substance or alcohol dependence at enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Acute schizophrenia</keyword>
</DOC>